Cultivation of Artemisia annua—the environmental perspective

Publikation: Bidrag til bog/antologi/rapport › Bidrag til bog/antologi › Forskning › fagfællebedømt

Standard

Cultivation of Artemisia annua—the environmental perspective. / Sjøholm, Karina Knudsmark; Strobel, Bjarne W.; Cedergreen, Nina.

Artemisia Annua: Prospects, Applications and Therapeutic Uses. CRC Press, 2017. s. 131-154.

Publikation: Bidrag til bog/antologi/rapport › Bidrag til bog/antologi › Forskning › fagfællebedømt

Harvard

Sjøholm, KK, Strobel, BW & Cedergreen, N 2017, Cultivation of Artemisia annua—the environmental perspective. i Artemisia Annua: Prospects, Applications and Therapeutic Uses. CRC Press, s. 131-154. https://doi.org/10.1201/b22102

APA

Sjøholm, K. K., Strobel, B. W., & Cedergreen, N. (2017). Cultivation of Artemisia annua—the environmental perspective. I Artemisia Annua: Prospects, Applications and Therapeutic Uses (s. 131-154). CRC Press. https://doi.org/10.1201/b22102

Vancouver

Sjøholm KK, Strobel BW, Cedergreen N. Cultivation of Artemisia annua—the environmental perspective. I Artemisia Annua: Prospects, Applications and Therapeutic Uses. CRC Press. 2017. s. 131-154 https://doi.org/10.1201/b22102

Author

Sjøholm, Karina Knudsmark ; Strobel, Bjarne W. ; Cedergreen, Nina. / Cultivation of Artemisia annua—the environmental perspective. Artemisia Annua: Prospects, Applications and Therapeutic Uses. CRC Press, 2017. s. 131-154

Bibtex

@inbook{ccf09196825d413fafac8757cd143666,
title = "Cultivation of Artemisia annua—the environmental perspective",
abstract = "Bioactive secondary metabolites represent a wide range of different chemical compounds, but the three major classes are nitrogen-containing compounds, phenols, and terpenes. Artemisinin, produced by Artemisia annua L. (sweet wormwood, annual wormwood, sweet annie, sweet sagewort) belongs to the terpenes group. Artemisinin is a sesquiterpene lactone with an endoperoxide bridge (Liu et al., 1979), and is very bioactive against chloroquine-resistant strains of the malaria parasite Plasmodium falciparum (Klayman, 1985). Today, combination therapies containing artemisinin are recommended as the first-line treatment for malaria in 77 out of 80 countries and amounted to 311 million treatments worldwide in 2015 (WHO, 2015).",
author = "Sj{\o}holm, {Karina Knudsmark} and Strobel, {Bjarne W.} and Nina Cedergreen",
year = "2017",
doi = "10.1201/b22102",
language = "English",
isbn = "9781138632103",
pages = "131--154",
booktitle = "Artemisia Annua",
publisher = "CRC Press",

}

RIS

TY - CHAP

T1 - Cultivation of Artemisia annua—the environmental perspective

AU - Sjøholm, Karina Knudsmark

AU - Strobel, Bjarne W.

AU - Cedergreen, Nina

PY - 2017

Y1 - 2017

N2 - Bioactive secondary metabolites represent a wide range of different chemical compounds, but the three major classes are nitrogen-containing compounds, phenols, and terpenes. Artemisinin, produced by Artemisia annua L. (sweet wormwood, annual wormwood, sweet annie, sweet sagewort) belongs to the terpenes group. Artemisinin is a sesquiterpene lactone with an endoperoxide bridge (Liu et al., 1979), and is very bioactive against chloroquine-resistant strains of the malaria parasite Plasmodium falciparum (Klayman, 1985). Today, combination therapies containing artemisinin are recommended as the first-line treatment for malaria in 77 out of 80 countries and amounted to 311 million treatments worldwide in 2015 (WHO, 2015).

AB - Bioactive secondary metabolites represent a wide range of different chemical compounds, but the three major classes are nitrogen-containing compounds, phenols, and terpenes. Artemisinin, produced by Artemisia annua L. (sweet wormwood, annual wormwood, sweet annie, sweet sagewort) belongs to the terpenes group. Artemisinin is a sesquiterpene lactone with an endoperoxide bridge (Liu et al., 1979), and is very bioactive against chloroquine-resistant strains of the malaria parasite Plasmodium falciparum (Klayman, 1985). Today, combination therapies containing artemisinin are recommended as the first-line treatment for malaria in 77 out of 80 countries and amounted to 311 million treatments worldwide in 2015 (WHO, 2015).

UR - http://www.scopus.com/inward/record.url?scp=85054220477&partnerID=8YFLogxK

U2 - 10.1201/b22102

DO - 10.1201/b22102

M3 - Book chapter

AN - SCOPUS:85054220477

SN - 9781138632103

SP - 131

EP - 154

BT - Artemisia Annua

PB - CRC Press

ER -

ID: 214399963